In conclusion, our study identified the key role of RHOJ and the mechanisms by which RHOJ promotes resistance to chemotherapy in EMT tumour cells, with important implications for the development of new strategies to overcome resistance to anticancer therapy. The gene discussed is RHOJ; the disease is neoplasm.